The global influenza medication market is anticipated to grow at a considerable CAGR of 7.2% during the forecast period (2022-2028). All the major players in the influenza medication market are involved in strategic alliances like acquisitions, partnerships, collaborations, and the launching of new drugs and vaccines to provide advanced treatment for influenza disease globally. Recently, in January 2022, the ResVax vaccine, a vaccine developed by Novavax Co. for RSV disease has completed its phase four trial and the outcomes have been announced at the IDSOG meeting. Emergent BioSolutions Co. has also developed a vaccine for influenza treatment named NuThrax anthrax Vaccine.
Browse the full report description of “Global Influenza Medication Market Size, Share & Trends Analysis Report by Treatment (Baloxavir Marboxil, Oseltamivir Phosphate, Others), by Route of Administration (Oral, Others) and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) Forecast (2022-2028)” at https://www.omrglobal.com/industry-reports/influenza-medication-market
For this, the company has enrolled patients to start their phase three trial for a clinical study. This vaccine will help to improve the immune system of the body to fight influenza. In December 2019, Genentech, Inc. also had announced the FDA approval of Xofluza a type of Baloxavir Marboxil for an individual at an elevated risk of developing influenza-related complications. Similarly, in November 2020, Shionogi & Co. announced the filing of a supplemental new drug application for Xofluza, a kind of Baloxavir marboxil drug in Japan for treating influenza virus infection. Moreover, in February 2018, this company has also announced the approval of Xofluza 20 mg tablets for oral administration for the treatment of influenza type A and type B in patients over 12 in Taiwan.
Market Coverage
Segment Covered-
Regions Covered-
Competitive Landscape - BIOCRYST PHARMACEUTICALs, INC., Genentech, Inc., GlaxoSmithKline Plc., Lupin Ltd., Seqirus (CSL), and others
Key questions addressed by the report
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Global Influenza Medication Market Report Segment
By Treatment Type
By Route of Administration
By Distribution Channel
Global Influenza Medication Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/influenza-medication-market